Clinical Trial: Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
Brief Summary: This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.
Detailed Summary:
Sponsor: Cxlusa
Current Primary Outcome: Resolution of Signs and Symptoms of Infectious Keratitis [ Time Frame: Subjects will be followed until resolution of signs and symptoms, an expected average of 8 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Cxlusa
Dates:
Date Received: November 27, 2012
Date Started: August 2011
Date Completion:
Last Updated: February 1, 2017
Last Verified: August 2015